Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent May 26, 2021
Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights April 22, 2021
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta April 8, 2021
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights November 27, 2020
